Document Actions
Intercell Launches Phase I Clinical Trials of TB Vaccine
Austrian vaccine developer Intercell on Tuesday announced that it has launched Phase I clinical trials of a new preventive tuberculosis vaccine, APA Economics News Service reports.
Intercell is working with the Statens Serum Institut and the Aeras Global TB Vaccine Foundation to develop the vaccine (APA Economics News Service, 12/4).